Advanced Drainage Systems, Inc. — Form 10-K Summary
Reporting period: The filing covers fiscal 2021, ended March 31, 2021, and was filed May 27, 2021. This does not match the request metadata’s “2019 Q4.” Fiscal 2020 is the primary comparison period. ADS manufactures drainage, stormwater, and on-site septic wastewater products; its segments are Pipe, Infiltrator, International, and Allied Products & Other. The Infiltrator acquisition closed July 31, 2019.
Financial performance and liquidity
| Metric | Fiscal 2021 | Fiscal 2020 |
|---|---|---|
| Net sales | $1,982.8 million | $1,673.8 million |
| Gross profit / margin | $690.1 million / 34.8% | $316.5 million / 18.9% |
| Operating income (loss) | $344.5 million | $(95.3) million |
| Net income (loss) | $226.1 million | $(191.8) million |
| Diluted earnings (loss) per share | $2.59 | $(3.21) |
| Adjusted EBITDA / margin | $567.0 million / 28.6% | $361.9 million / 21.6% |
| Cash from operating activities | $452.2 million | $306.2 million |
| Capital expenditures | $78.8 million | $67.7 million |
| Free cash flow | $373.5 million | $238.5 million |
- Sales by reportable segment, external customers: Pipe $1,052.9 million (+10.5%); Infiltrator $329.1 million (+94.4%); International $158.3 million (+6.5%); Allied Products & Other $442.4 million (+9.7%).
- Balance sheet and liquidity at March 31, 2021: Cash $195.0 million; working capital $424.7 million; debt excluding finance leases $791.3 million; debt and finance lease obligations $841.5 million; net debt, as defined by the company, $646.5 million. Revolver availability was $339.0 million after letters of credit. The company reported a 1.1 leverage ratio.
- Cash returns: Fiscal 2021 quarterly common dividends were $0.09 per share. In the first quarter of fiscal 2022, ADS declared a $0.11 quarterly dividend and authorized a new $250 million stock-repurchase program, alongside approximately $42 million remaining under the prior authorization.
Material changes versus the prior comparable period
- Sales rose 18.5%, reflecting stronger domestic Pipe and Allied Products & Other demand, and a full year of Infiltrator results versus eight months in fiscal 2020.
- Profitability improved substantially, but the comparison is heavily affected by fiscal 2020’s $246.8 million ESOP special-dividend compensation expense—$168.6 million in cost of goods sold and $78.1 million in SG&A. The special charge did not recur in fiscal 2021.
- Management also attributed higher gross profit to increased volume, improved pricing and product mix, lower material costs, manufacturing efficiencies, and the full-year Infiltrator contribution.
- Interest expense declined to $35.7 million from $82.7 million, largely because fiscal 2020 included debt-extinguishment and financing-cost charges and because debt levels fell. Fiscal 2021 included $207 million of Term Loan repayments and $100 million of revolver repayments.
- Operating cash flow increased 47.7%; free cash flow increased 56.6%. Debt excluding finance leases declined approximately $308.5 million from March 31, 2020.
Outlook, risks, contingencies, and unusual items
- Management expected fiscal 2022 capital expenditures of approximately $130–$150 million, primarily funded from operations. It stated that cash, operating cash generation, and available revolver capacity should meet anticipated requirements for at least the next 12 months. No numerical revenue or earnings guidance is provided in the supplied filing text.
- COVID-19 was identified as an ongoing uncertainty, with potential effects on supply availability and cost, employee availability, project schedules, customer demand, deliveries, and collections. Facilities remained open under health and safety protocols; the company deferred its share of Social Security payroll taxes under the CARES Act, with repayment due in 2021 and 2022.
- Key business risks include volatile HDPE and polypropylene resin prices and the ability to pass cost increases through to customers; construction, agriculture, and infrastructure cyclicality and weather-related seasonality; competition; customer concentration; working-capital and credit risks; acquisition integration; variable-rate debt; and environmental, product-liability, cybersecurity, and international/joint-venture exposures.
- Two customers, Ferguson Enterprises and Core & Main, represented 12.6% and 10.3% of fiscal 2021 sales, respectively. Together, the two represented 22.8% of sales. Ferguson represented approximately 18.1% of receivables at year-end.
- Debt includes $441.3 million under the Term Loan Facility and $350 million of 5.0% Senior Notes due 2027. The Term Loan Facility matures in 2026; the revolver matures in 2024. ADS reported compliance with debt covenants at year-end. A 1% increase in rates on variable-rate debt was estimated to increase annual interest expense by about $4.4 million.
- The South American joint-venture debt guarantee had a maximum potential obligation of $11 million; approximately $5 million was guaranteed against $10 million of outstanding debt at year-end. Management did not expect the guarantee to affect current or future financial condition materially. Ordinary-course litigation was not expected by the company to have a material adverse impact.
- Fiscal 2021 restructuring actions included headcount reductions and cost elimination; $4.3 million was recorded for asset disposals and exit/disposal costs, including $1.9 million of restructuring expense. No additional restructuring cost estimate or end date was provided.
- Goodwill totaled $599.1 million, including $495.8 million assigned to Infiltrator. The estimated Infiltrator fair value exceeded carrying value by more than 25%, but the valuation depends on forecasts and assumptions; Deloitte identified this valuation as a critical audit matter. No goodwill or intangible-asset impairment was recorded in fiscal 2021.
- The company said it remediated the material weakness previously identified in fiscal 2019. Management and Deloitte concluded internal control over financial reporting was effective as of March 31, 2021; Deloitte issued unqualified opinions on the financial statements and internal controls.
Important facts for investors to verify
- Confirm the intended filing period: this is a fiscal 2021 10-K, not a 2019 Q4 filing.
- Separate recurring operating performance from the unusually large fiscal 2020 ESOP special-dividend charge and from acquisition-related timing and costs; review the company’s Adjusted EBITDA reconciliation and its non-GAAP limitations.
- Assess how much growth and cash generation are sustainable after normalizing for the full-year Infiltrator contribution, pricing, input costs, and working-capital changes.
- Review the Infiltrator goodwill valuation assumptions and sensitivity, as well as acquisition integration progress and the contribution of the acquired business.
- Check debt amortization, variable-rate exposure, covenant headroom, lease obligations, and the funding implications of planned capital spending, dividends, and repurchases.
- Monitor resin cost and supply trends, customer concentration and receivables exposure, and the status of COVID-related supply, project, and collection risks.